Supernus, Inc. (SUPN): who owns it and who trades it
As of Nov 3, 2026, SUPN insiders reported 3 open-market sales worth $2.8M and 7 purchases worth $229K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christian Heidbreder (Chief Scientific Officer), with $1.5M.
Latest filing Nov 3, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, SUPN insiders reported $229K of open-market purchases and $2.8M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Woodrow D Anderson | Chief Accounting Officer | Purchase | 1,500 | $35.69 | $53.5K | Form 4 |
| Aug 5, 2026 | Woodrow D Anderson | Chief Accounting Officer | Purchase | 1,500 | $36.28 | $54.4K | Form 4 |
| Jul 10, 2026 | Christian Heidbreder | Chief Scientific Officer | Sale plan | 18,586 | $41.14 | $765K | Form 4 |
| Jun 11, 2026 | Christian Heidbreder | Chief Scientific Officer | Sale plan | 18,586 | $38.06 | $707K | Form 4 |
| Jun 8, 2026 | Ryan Preblick | CFO | Sale plan | 36,000 | $37.70 | $1.4M | Form 4 |
| Mar 13, 2026 | Barbara Ryan | Director | Purchase | 8 | $31.09 | $249 | Form 4 |
| Mar 9, 2026 | Barbara Ryan | Director | Purchase | 31 | $32.56 | $1K | Form 4 |
| Mar 6, 2026 | Stuart A Kingsley | Director | Purchase | 940 | $31.87 | $30K | Form 4 |
| Jan 5, 2026 | Barbara Ryan | Director | Purchase plan | 775 | $35.39 | $27.4K | Form 4 |
| Jan 5, 2026 | David E. Wheadon | Director | Purchase plan | 1,771 | $35.39 | $62.7K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Christian Heidbreder | Chief Scientific Officer | – | $1.5M | Jul 10, 2026 |
| Ryan Preblick | Chief Financial Officer | – | $1.4M | Jun 8, 2026 |
| Woodrow D Anderson | Chief Accounting Officer | $108K | – | Aug 27, 2026 |
| David E. Wheadon | Director | $62.7K | – | Jan 5, 2026 |
| Stuart A Kingsley | Director | $30K | – | Mar 6, 2026 |
| Barbara Ryan | Director | $28.7K | – | Mar 13, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SUPN short interest
Low short interest. 3.9% of SUPN shares are sold short: about 1 share in 26. Over the last 12 reports the number of shares short went down 2%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.62M SUPN shares were sold short, 3.9% of the shares outstanding, up 14.2% from the report before. At the average daily volume of 1.35M shares, buying them all back would take about 3.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.62M | 3.91% | +14% | 1.35M | 3.4 |
| Oct 15, 2026 | 4.04M | 3.43% | -19% | 819,879 | 4.9 |
| Sep 30, 2026 | 4.99M | 4.22% | -0% | 675,999 | 7.4 |
| Sep 15, 2026 | 4.99M | 4.23% | +7% | 576,525 | 8.7 |
| Aug 31, 2026 | 4.67M | 3.96% | +13% | 565,443 | 8.3 |
| Aug 14, 2026 | 4.15M | 3.51% | -14% | 1.48M | 2.8 |
| Jul 31, 2026 | 4.82M | 4.08% | -1% | 506,478 | 9.5 |
| Jul 15, 2026 | 4.85M | 3.98% | -32% | 947,818 | 5.1 |
| Jun 30, 2026 | 7.14M | 5.86% | +17% | 1.03M | 7.0 |
| Jun 15, 2026 | 6.10M | 5.01% | +13% | 602,836 | 10.1 |
| May 29, 2026 | 5.42M | 4.44% | +15% | 570,435 | 9.5 |
| May 15, 2026 | 4.73M | 3.88% | +0% | 894,396 | 5.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded SUPN
Since Nov 17, 2024, 1 member of Congress reported 3 purchases and 1 sale of SUPN. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Mar 3, 2026, reported Apr 7, 2026.
Purchases 3Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Apr 7, 2026 | Report |
| Dec 11, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jan 12, 2026 | Report |
| Oct 9, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Nov 18, 2025 | Report |
| Mar 24, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Apr 7, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Supernus company events
Supernus filed 23 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, control). The latest was on Nov 3, 2026.
- Nov 3, 2026AnnouncementMade another announcement. Filing
- Nov 2, 2026LeadershipDeparture of Officers Consistent with the terms of the Merger Agreement, effective as of the Effective Time, Joseph Ciaffoni ceased to serve as Chief Executive Officer of Indivior, Ryan Preblick ceased to serve as Chief Financial Officer of Indivior, Patrick Barry ceased to serve as Chief… Filing
- Oct 29, 2026ResultsReleased financial results. Filing
- Oct 15, 2026VoteReported shareholder vote results. Filing
- Oct 6, 2026AnnouncementAs previously reported, on August 1, 2026, Indivior Pharmaceuticals, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., a Delaware corporation and Artemis Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Indivior. Filing
- Sep 17, 2026AnnouncementOf this Current Report on Form 8-K). Filing
- Sep 15, 2026AgreementEnded an important agreement. Filing
- Aug 3, 2026AnnouncementShared information with investors. Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- Aug 3, 2026AgreementIndivior Pharmaceuticals, Inc., a Delaware corporation and Artemis Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Indivior, entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., a Delaware corporation. Filing
- May 15, 2026LeadershipIndivior Pharmaceuticals, Inc. will eliminate the position of Chief Scientific Officer. Filing
- May 4, 2026AnnouncementShared information with investors. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Mar 17, 2026AgreementIndivior Pharmaceuticals, Inc. issued $500 million principal amount of its 0.625% Convertible Senior Notes due 2031. Filing
- Mar 13, 2026AnnouncementThe Company announced the pricing of its offering of 0.625% convertible senior notes due 2031. Filing
- Mar 12, 2026AnnouncementThe Company announced the launch of its proposed offering of convertible senior notes due 2031. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 26, 2026ControlThe information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. Filing
- Jan 8, 2026AnnouncementShared information with investors. Filing
- Dec 22, 2025AnnouncementShared information with investors. Filing
- Dec 18, 2025LeadershipThe Board of Directors of Indivior PLC approved the following base salary changes for the Company's executive officers, effective January 1, 2026, based on a review of the competitive market and the recommendations of the Compensation Committee and the Board's compensation consultant: Joseph… Filing
- Dec 15, 2025VoteReported shareholder vote results. Filing
- Nov 20, 2025AgreementEnded an important agreement. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Supernus financials
Questions about Supernus, Inc. (SUPN) stock
Are SUPN insiders buying or selling?
In the last 12 months, SUPN insiders reported 7 open-market purchases worth $229K and 3 sales worth $2.8M. The latest trade was on Aug 27, 2026. See every trade.
What is the short interest in SUPN?
As of Oct 30, 2026, 4.62M SUPN shares were sold short, 3.9% of the shares outstanding, up 14.2% from the report before. At the average daily volume of 1.35M shares, buying them all back would take about 3.4 trading days (days to cover). See the history.
Have members of Congress traded SUPN?
Yes. 1 member of Congress reported 3 purchases and 1 sale of SUPN since Nov 17, 2024. The latest was reported on Apr 7, 2026. See the trades.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.